Tropic Biosciences banks $28.5m in Temasek-led Series B for gene-editing, RNAi approach

Losing a crop to a pest or disease is a devastating outcome for a farmer. If that farmer is based in a developing country without the promise of subsidies or crop insurance, it’s even direr. And in a pandemic world where food supply chains have tightened and been disrupted, the idea of losing whole fields of crops to disease seems unconscionable as many consumers across the world struggle to get hold of their usual staples.

Read the whole article